EDIT - Editas Medicine, Inc.
NEXT EARNINGS:
Mar 4, 2026
(in 7 days)
EPS Est: $-0.27
|
Rev Est: $8.8M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$12.85
DETAILS
HIGH:
$35.00
LOW:
$5.00
MEDIAN:
$12.00
CONSENSUS:
$12.85
UPSIDE:
509.00%
Market Cap:
205.98M
Volume:
3,598,544
Avg Volume:
1,688,845
52 Week Range:
0.91-4.537
Sector:
Healthcare
Industry:
Biotechnology
Beta:
2.19
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
246
IPO Date:
2016-02-03
EPS (TTM):
-2.88
P/E Ratio:
-0.44
Revenue (TTM):
32.31M
Total Assets:
341.59M
Total Debt:
35.03M
Cash & Equiv:
131.54M
Rev Growth (5Y):
9.5%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-90.4%
Debt/Equity:
0.26
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-10 | $-0.28 | $-0.38 | +26.3% | $7.5M | $8.5M | -10.8% |
| 2025-08-12 | $-0.63 | $-0.41 | -53.7% | $3.6M | $1.8M | +97.0% |
| 2025-05-12 | $-0.43 | $-0.51 | +15.7% | $4.7M | $706100 | +559.7% |
| 2025-03-05 | $-0.55 | $-0.39 | -41.0% | $30.6M | $640250 | +4680.0% |
| 2024-11-04 | $-0.75 | $-0.76 | +1.3% | $61000 | $28.9M | -99.8% |
| 2024-08-07 | $-0.82 | $-0.69 | -18.8% | $513000 | $5.1M | -89.9% |
| 2024-05-08 | $-0.76 | $-0.63 | -20.6% | $1.1M | $7.9M | -85.6% |
| 2024-02-28 | $-0.23 | $-0.52 | +55.8% | $60.0M | $7.9M | +656.3% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 32.31M | 78.12M | 19.71M | 25.54M | 90.73M | 20.53M | 31.94M | 13.73M | 6.05M | 1.63M | 0 | 0 |
| Net Income | (237.09M) | (153.22M) | (220.43M) | (192.50M) | (115.98M) | (133.75M) | (109.95M) | (120.32M) | (97.18M) | (72.90M) | (13.69M) | (5.35M) |
| EPS | -2.88 | -2.02 | -3.21 | -2.85 | -1.98 | -2.47 | -2.33 | -2.98 | -3.02 | -2.04 | -5.34 | -0.18 |
| Total Assets | 341.59M | 499.15M | 514.32M | 677.48M | 572.60M | 508.88M | 420.39M | 373.26M | 229.18M | 149.36M | 12.19M | 2.48M |
| Total Debt | 35.03M | 48.54M | 43.95M | 26.38M | 26.14M | 29.08M | 32.42M | 33.43M | 35.10M | 199.91M | 411,000 | 2.11M |
| Cash & Equivalents | 131.54M | 123.65M | 141.52M | 203.52M | 139.68M | 238.18M | 134.78M | 146.63M | 185.32M | 143.18M | 10.62M | 2.01M |
| Operating Cash Flow | (210.28M) | (132.18M) | (177.35M) | (163.80M) | (179.84M) | (40.67M) | (45.71M) | (9.42M) | (49.93M) | (5.40M) | (8.65M) | (2.78M) |
| Free Cash Flow | (219.11M) | (136.90M) | (181.47M) | (171.78M) | (187.00M) | (46.84M) | (50.46M) | (11.48M) | (53.42M) | (6.83M) | (9.87M) | (2.94M) |
| FCF per Share | -2.66 | -1.80 | -2.64 | -2.54 | -3.19 | -0.94 | -1.07 | -0.28 | -1.66 | -0.19 | -3.85 | -0.10 |
| Book Value | 134.27M | 349.10M | 360.68M | 553.64M | 393.59M | 262.44M | 236.16M | 208.08M | 134.61M | (83.11M) | (15.29M) | (1.76M) |
| Cash & ST Investments | 269.91M | 323.11M | 344.27M | 499.85M | 402.11M | 457.14M | 368.95M | 329.14M | 185.32M | 143.18M | 10.62M | 2.01M |
| ROC Equity | -1.77 | -0.44 | -0.61 | -0.35 | -0.29 | -0.51 | -0.47 | -0.58 | -0.72 | N/A | N/A | N/A |